Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EF5 Uptake and Oxygen-Related Metabolites in Head and Neck Cancer
NCT00049140Phase 2Completed
- Start
- Aug 2002
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ef5 in head and neck cancer (HNC). Started Aug 2002; status: completed.
02
Drugs
ef5
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00049140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049140.